Truveta delivers the most complete, timely, and clean electronic health record (EHR) data from more than 30 health systems, empowering researchers with scientifically rigorous, fast, and compliant analytics to study safety and effectiveness, improve patient care, and train medical AI.
Using the precise vascular device details – including universal device identification numbers (UDI) – within Truveta Data, Medical Components will be able to study the real-world use of their devices, identifying innovative optimizations and opportunities for improvement in patient care.
“Clear evidence gaps and conflicting narratives on the efficacy of different devices exist in the market today. By partnering with Truveta, we will get actionable insights to help address these gaps and advance research in the care and treatment of the patients we serve, ultimately leading to improved clinical recommendations and state-of-the-art product enhancements,” said George Miller, Director of Clinical Affairs, Medical Components, Inc.
Through the power of real-world data, we can unlock critical patient insights with device-level detail to help Medical Components advance the innovation of vascular access device technologies and identify new potential clinical recommendations.”
